BioSpace News Archive

Policy

Cinfa Biotech receives positive CHMP opinion for Pelmeg® (pegfilgrastim), a proposed biosimilar to Neulasta®

Cinfa Biotech today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorization for Pelmeg® (B12019)

September 22, 2018
·
2 min read
Policy

National Institutes of Health Awards Palantir with Contract to Advance Critical Health Research

Palantir Technologies announced today that it has been awarded a three-year, $7 million contract by the National Institutes of Health (NIH).

September 22, 2018
·
1 min read
Business

InflaRx N.V. Announces Appointment of Jens Holstein to Board of Directors

InflaRx N.V. announced today that Jens Holstein has been appointed as a new board member of InflaRx, serving as Non-Executive Director.

September 22, 2018
·
4 min read
Business

Charcot Marie Tooth (CMT) Experts Launch National Nonprofit to Fund Only Treatments and Cures

CMT Research Foundation to Speed Dollars to Most Promising Research

September 22, 2018
·
8 min read
Business

VistaGen Therapeutics Acquires Worldwide License of Phase 3-Ready CNS Drug Candidate from Pherin Pharmaceuticals for As-Needed Treatment of Social Anxiety Disorder

Phase 3-ready asset expands VistaGen’s CNS pipeline and complements its neuropsychiatry focus on Major Depressive Disorder (MDD) with AV-101

September 22, 2018
·
9 min read
Business

Abingworth appoints Brian Gallagher, Jr as Partner

Abingworth today announced that Brian Gallagher, PhD, will join Abingworth as a Partner based in the company’s Boston office.

September 22, 2018
·
2 min read